Casdin Capital, LLC Zai Lab LTD Transaction History

Casdin Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $3.47 Million - $7.45 Million	-150,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $2.2 Million - $4.21 Million	-40,000 Reduced 21.05%	150,000 $9.43 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $7.43 Million - $12 Million	190,000 New	190,000 $9.78 Million
Q3 2018 Nov 14, 2018	SELL	$17.8 - $25.35 $2.4 Million - $3.42 Million	-135,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$20.05 - $26.96 $2.71 Million - $3.64 Million	135,000 New	135,000 $2.88 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.